kinase b (pknb) inhibitors: synthesis and sar study

88
Supporting Information Substituted 4-oxo-crotonic acid derivatives as a new class of Protein kinase B (PknB) inhibitors: synthesis and SAR study Changliang Xu, a,b,† Xiaoguang Bai, a,† Jian Xu, a Jinfeng Ren, a Yun Xing, a Ziqiang Li, a Juxian Wang, a Jingjing Shi, b Liyan Yu* ,a and Yucheng Wang* ,a a. Institute of Medicinal Biotechnology, Chinese Academy of Medical Science & Peking Union Medical College, Beijing 100050, China. E-mail address: [email protected] (L.Y.Y.); [email protected] (Y.C.W.); Tel. /Fax: +86-010-6318-7118 (L.Y.Y.); +86-010-6316-5263 (Y.C.W.). b. Jiangsu Protein Drug Engineering Laboratory , Food & Drug Analysis and Testing Center, Jiangsu Food & Pharmaceutical Science College, Huai’an 223003, Jiangsu, China. E-mail address: [email protected]; Tel: +86-0517-87088209. These authors contributed equally to this work. NMR spectra of synthesized compounds: 1b 1c Electronic Supplementary Material (ESI) for RSC Advances. This journal is © The Royal Society of Chemistry 2016

Upload: others

Post on 03-Oct-2021

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: kinase B (PknB) inhibitors: synthesis and SAR study

Supporting Information

Substituted 4-oxo-crotonic acid derivatives as a new class of Protein

kinase B (PknB) inhibitors: synthesis and SAR study

Changliang Xu,a,b,† Xiaoguang Bai,a,† Jian Xu,a Jinfeng Ren,a Yun Xing,a Ziqiang Li,a Juxian Wang,a Jingjing Shi,b Liyan Yu*,a and Yucheng Wang*,a

a. Institute of Medicinal Biotechnology, Chinese Academy of Medical Science & Peking Union Medical College, Beijing 100050, China. E-mail

address: [email protected] (L.Y.Y.); [email protected] (Y.C.W.); Tel. /Fax: +86-010-6318-7118 (L.Y.Y.); +86-010-6316-5263 (Y.C.W.).

b.Jiangsu Protein Drug Engineering Laboratory , Food & Drug Analysis and Testing Center, Jiangsu Food & Pharmaceutical Science College,

Huai’an 223003, Jiangsu, China. E-mail address: [email protected]; Tel: +86-0517-87088209.

† These authors contributed equally to this work.

NMR spectra of synthesized compounds:1b

1c

Electronic Supplementary Material (ESI) for RSC Advances.This journal is © The Royal Society of Chemistry 2016

Page 2: kinase B (PknB) inhibitors: synthesis and SAR study

2a

2b

Page 3: kinase B (PknB) inhibitors: synthesis and SAR study

2c

Page 4: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

28.9

7

32.8

539

.10

39.2

439

.38

39.5

239

.66

39.8

039

.94

55.5

0

113.

83

129.

6113

0.10

163.

00

173.

36

197.

26

BRUKER AVANCE III 13C-NMR 2c IN DMSO-d6

NH2

O

O

O

3a

3b

Page 5: kinase B (PknB) inhibitors: synthesis and SAR study

3c

Page 6: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

27.1

133

.79

34.4

939

.10

39.2

439

.38

39.5

239

.66

39.8

039

.94

54.9

5

113.

68

129.

21

133.

67

157.

39

174.

04

BRUKER AVANCE III 13C-NMR 3c IN DMSO-d6

O

NH2

O

4

7a

Page 7: kinase B (PknB) inhibitors: synthesis and SAR study

7b

7c

Page 8: kinase B (PknB) inhibitors: synthesis and SAR study

7d

7e

Page 9: kinase B (PknB) inhibitors: synthesis and SAR study

7f

7g

Page 10: kinase B (PknB) inhibitors: synthesis and SAR study

7h

7i

Page 11: kinase B (PknB) inhibitors: synthesis and SAR study

7j

7k

Page 12: kinase B (PknB) inhibitors: synthesis and SAR study

7l

7m

Page 13: kinase B (PknB) inhibitors: synthesis and SAR study

7n

7o

Page 14: kinase B (PknB) inhibitors: synthesis and SAR study

7p

7q

Page 15: kinase B (PknB) inhibitors: synthesis and SAR study

7r

7s

Page 16: kinase B (PknB) inhibitors: synthesis and SAR study

7t

8a

Page 17: kinase B (PknB) inhibitors: synthesis and SAR study

8b

Page 18: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

4

52.2

3

128.

8412

9.05

131.

2113

4.10

136.

0113

6.89

165.

38

189.

23

BRUKER AVANCE III 13C-NMR 8b IN DMSO-d6

O

O

O

8c

Page 19: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

21.2

5

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

4

52.2

0

128.

9912

9.63

130.

9413

3.57

136.

93

144.

83

165.

43

188.

54

BRUKER AVANCE III 13C-NMR 8c IN DMSO-d6

O

O

O

8d

Page 20: kinase B (PknB) inhibitors: synthesis and SAR study

8e

Page 21: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

4

52.1

9

56.0

1

112.

69

120.

83

126.

8012

8.93

130.

1413

4.81

140.

77

158.

68

165.

62

190.

57

BRUKER AVANCE III 13C-NMR 8e IN DMSO-d6

O

O

OO

8f

Page 22: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

4

52.2

155

.39

112.

82

120.

3712

1.53

130.

2213

1.28

136.

8513

7.41

159.

62

165.

38

188.

95

BRUKER AVANCE III 13C-NMR 8f IN DMSO-d6

O

O

O

O

8g

Page 23: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

4

52.2

055

.60

56.5

0

113.

7811

4.35

120.

84

127.

0712

8.99

140.

71

153.

0415

3.15

165.

61

190.

19

BRUKER AVANCE III 13C-NMR 8g IN DMSO-d6

O

O

O

O

O

8h

Page 24: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

4

52.1

655

.53

55.8

5

110.

3911

0.95

124.

3212

9.02

130.

52

136.

77

149.

02

154.

07

165.

53

186.

98

BRUKER AVANCE III 13C-NMR 8h IN DMSO-d6

O

O

O

O

O

8i

Page 25: kinase B (PknB) inhibitors: synthesis and SAR study

8j

Page 26: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

28.2

5

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

4

52.1

5

72.4

5

109.

21

126.

3612

8.88

129.

3213

0.35

131.

11

137.

22

164.

8916

5.53

186.

85

BRUKER AVANCE III 13C-NMR 8j IN DMSO-d6

O

O

OO

8k

Page 27: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

4

52.2

5

127.

0712

7.21

128.

6412

9.15

129.

6413

1.14

134.

8513

6.93

138.

6514

5.40

165.

43

188.

65

BRUKER AVANCE III 13C-NMR 8k IN DMSO-d6

O

O

O

8l

Page 28: kinase B (PknB) inhibitors: synthesis and SAR study

8m

Page 29: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

4

52.1

6

124.

7212

5.12

126.

6512

8.12

128.

6512

9.74

129.

9613

1.52

133.

4513

3.50

133.

5913

9.95

165.

34

192.

55

BRUKER AVANCE III 13C-NMR 8m IN DMSO-d6

O

O

O

8n

8o

Page 30: kinase B (PknB) inhibitors: synthesis and SAR study

8p

Page 31: kinase B (PknB) inhibitors: synthesis and SAR study

-100102030405060708090100110120130140150160170180190200210f1 (ppm)

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

3

52.2

7

128.

3613

0.84

131.

5013

2.12

135.

0113

6.60

165.

33

188.

50

BRUKER AVANCEⅢ13C-NMR 8p IN DMSO-d6

O

O

OBr

8q

Page 32: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

4

52.2

4

113.

29

121.

68

130.

72

136.

10

149.

7315

1.97

165.

27

175.

46

BRUKER AVANCE III 13C-NMR 8q IN DMSO-d6

O

O

OO

8r

8s

Page 33: kinase B (PknB) inhibitors: synthesis and SAR study

-100102030405060708090100110120130140150160170180190200210f1 (ppm)

24.8

825

.37

27.6

8

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

447

.97

52.1

9

129.

68

138.

83

165.

59

202.

32

BRUKER AVANCEⅢ13C-NMR 8S IN DMSO-d6

O

O

O

8t

Page 34: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

11.7

6

19.4

4

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

4

52.1

5

129.

80

139.

62

165.

61

199.

42

BRUKER AVANCE III 13C-NMR 8t IN DMSO-d6

O

O

O

9a

Page 35: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

13.9

9

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

4

55.6

6

60.9

3

114.

33

129.

0013

0.91

131.

36

136.

81

163.

9516

5.00

187.

14

O

O

O

O

BRUKER AVANCE III 13C-NMR 9a IN DMSO-d6

9b

Page 36: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

13.9

5

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

4

60.9

8

128.

7812

8.99

131.

5713

4.01

136.

0213

6.64

164.

85

189.

15

BRUKER AVANCE III 13C-NMR 9b IN DMSO-d6

O

O

O

9c

Page 37: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

13.9

8

21.2

3

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

4

60.9

7

128.

9612

9.60

131.

3013

3.58

136.

74

144.

77

164.

92

188.

51

BRUKER AVANCE III 13C-NMR 9c IN DMSO-d6

O

O

O

9d

Page 38: kinase B (PknB) inhibitors: synthesis and SAR study

9e

Page 39: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

13.9

7

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

4

56.0

0

60.9

1

112.

70

120.

83

126.

8112

9.32

130.

1013

4.76

140.

68

158.

65

165.

11

190.

62

BRUKER AVANCE III 13C-NMR 9e IN DMSO-d6

O

O

OO

9f

Page 40: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

13.9

8

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

4

55.3

9

61.0

0

112.

82

120.

3212

1.52

130.

2213

1.65

136.

7413

7.42

159.

61

164.

88

188.

99

BRUKER AVANCE III 13C-NMR 9f IN DMSO-d6

O

O

O

O

9g

Page 41: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

13.9

6

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

4

55.5

756

.46

60.9

0

113.

7711

4.33

120.

76

127.

0812

9.35

140.

61

153.

0215

3.15

165.

10

190.

18

BRUKER AVANCE III 13C-NMR 9g IN DMSO-d6

O

O

O

O

O

9h

Page 42: kinase B (PknB) inhibitors: synthesis and SAR study

9i

Page 43: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

14.0

1

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

4

60.9

5

102.

36

107.

6410

8.30

126.

2213

0.79

131.

12

136.

74

148.

29

152.

45

164.

97

186.

88

BRUKER AVANCE III 13C-NMR 9i IN DMSO-d6

O

O

O

O

O

9j

Page 44: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

14.0

1

28.2

5

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

4

60.9

1

72.4

3

109.

19

126.

3212

8.85

129.

3213

0.70

131.

0813

7.03

164.

8716

5.03

186.

83

BRUKER AVANCE III 13C-NMR 9j IN DMSO-d6

O

O

OO

9k

Page 45: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

14.0

1

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

4

61.0

2

127.

0612

7.19

128.

6112

9.13

129.

6113

1.51

134.

8513

6.74

138.

6514

5.38

164.

93

188.

63

BRUKER AVANCE III 13C-NMR 9k IN DMSO-d6

O

O

O

9l

Page 46: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

13.9

9

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

4

60.9

8

117.

2712

0.23

125.

0413

0.40

131.

2713

1.59

136.

69

154.

65

162.

1216

4.93

187.

46

O

O

OO

115120125130135f1 (ppm)

117.

27

120.

23

125.

04

130.

4013

0.75

131.

2713

1.59

136.

69

BRUKER AVANCE III 13C-NMR 9l IN DMSO-d6

9m

Page 47: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

13.9

4

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

4

61.0

3

124.

8112

5.10

126.

7112

8.15

128.

6812

9.72

129.

9213

2.00

133.

4513

3.66

139.

97

164.

88

192.

82

BRUKER AVANCE III 13C-NMR 9m IN DMSO-d6

O

O

O

9n

Page 48: kinase B (PknB) inhibitors: synthesis and SAR study

9o

9p

Page 49: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

14.0

0

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

3

61.0

5

128.

3313

0.82

131.

8613

2.10

135.

0113

6.42

164.

83

188.

50

O

O

OBr

BRUKER AVANCE III 13C-NMR 9p IN DMSO-d6

9q

Page 50: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

13.9

8

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

4

61.0

3

113.

27

121.

59

131.

08

135.

96

149.

6815

1.98

164.

77

175.

50

O

O

OO

BRUKER AVANCE III 13C-NMR 9q IN DMSO-d6

9r

Page 51: kinase B (PknB) inhibitors: synthesis and SAR study

9s

Page 52: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

13.8

8

24.8

825

.37

27.7

139

.10

39.2

439

.38

39.5

239

.66

39.8

0

47.8

9

60.8

7

130.

00

138.

59

165.

01

202.

12

BRUKER AVANCE III 13C-NMR 9s IN DMSO-d6

O

O

O

9t

Page 53: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

11.7

713

.96

19.3

7

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

4

60.9

9

130.

26

139.

58

165.

16

199.

54

BRUKER AVANCE III 13C-NMR 9t IN DMSO-d6

O

O

O

10a

Page 54: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

21.4

9

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

4

55.6

5

68.5

3

114.

33

129.

0113

1.32

136.

66

163.

9416

4.50

187.

13

BRUKER AVANCE III 13C-NMR 10a IN DMSO-d6

O

O

O

O

10b

10c

Page 55: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

21.2

421

.48

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

4

68.5

8

128.

9612

9.61

131.

7113

3.58

136.

65

144.

76

164.

43

188.

56

BRUKER AVANCE III 13C-NMR 10c IN DMSO-d6

O

O

O

10d

Page 56: kinase B (PknB) inhibitors: synthesis and SAR study

10e

Page 57: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

21.4

6

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

4

55.9

7

68.4

6

112.

70

120.

82

126.

8112

9.73

130.

0613

4.71

140.

58

158.

62

164.

58

190.

64

BRUKER AVANCE III 13C-NMR 10e IN DMSO-d6

O

O

OO

10f

Page 58: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

21.4

3

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

4

55.3

4

68.5

9

112.

82

120.

2212

1.47

130.

1613

2.05

136.

5313

7.42

159.

59

164.

34

188.

92

BRUKER AVANCE III 13C-NMR 10f IN DMSO-d6

O

O

O

O

10g

Page 59: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

21.4

5

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

4

55.5

656

.44

68.4

6

113.

7511

4.34

120.

71

127.

0912

9.77

140.

52

153.

0015

3.15

164.

58

190.

20

BRUKER AVANCE III 13C-NMR 10g IN DMSO-d6

O

O

O

O

O

10h

Page 60: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

21.5

0

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

4

55.5

455

.87

68.5

3

110.

3811

0.97

124.

3512

9.04

131.

31

136.

59

149.

03

154.

06

164.

55

187.

05

BRUKER AVANCE III 13C-NMR 10h IN DMSO-d6

O

O

O

O

O

10i

Page 61: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

21.4

9

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

4

68.5

3

102.

35

107.

6210

8.27

126.

1713

0.79

131.

51

136.

56

148.

27

152.

42

164.

46

186.

86

BRUKER AVANCE III 13C-NMR 10i IN DMSO-d6

O

O

O

O

O

10j

Page 62: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

21.4

9

28.2

5

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

4

68.4

8

72.4

2

109.

18

126.

3012

8.84

129.

3213

1.07

131.

1113

6.88

164.

5316

4.85

186.

84

BRUKER AVANCE III 13C-NMR 10j IN DMSO-d6

O

O

OO

10k

Page 63: kinase B (PknB) inhibitors: synthesis and SAR study

10l

Page 64: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

21.5

0

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

4

68.6

0

117.

2912

0.24

125.

0513

0.41

131.

6013

1.67

136.

60

154.

65

162.

1216

4.45

187.

51

BRUKER AVANCE III 13C-NMR 10l IN DMSO-d6

129130131132133f1 (ppm)

130.

41

130.

76

131.

6013

1.67

O

O

OO

10m

10n

Page 65: kinase B (PknB) inhibitors: synthesis and SAR study

10o

10p

Page 66: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

21.4

9

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

4

68.6

8

128.

3013

0.82

132.

1013

5.02

136.

32

164.

33

188.

54

BRUKER AVANCE III 13C-NMR 10p IN DMSO-d6

O

O

OBr

10q

Page 67: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

21.4

6

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

4

68.6

6

113.

27

121.

50

131.

48

135.

83

149.

6315

1.98

164.

27

175.

53

BRUKER AVANCE III 13C-NMR 10q IN DMSO-d6

O

O

OO

10r

Page 68: kinase B (PknB) inhibitors: synthesis and SAR study

10s

Page 69: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

21.4

424

.87

25.3

727

.75

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

447

.74

68.5

1

130.

46

138.

55

164.

57

202.

34

BRUKER AVANCE III 13C-NMR 10s IN DMSO-d6

O

O

O

10t

Page 70: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

11.7

1

19.2

921

.47

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

3

68.6

0

130.

71

139.

51

164.

66

199.

58

BRUKER AVANCE III 13C-NMR 10t IN DMSO-d6

O

O

O

11a

Page 71: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

28.1

938

.82

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

3

55.7

1

64.0

7

77.8

5

114.

37

129.

0113

0.93

131.

38

136.

85

155.

71

164.

0016

4.92

187.

19

BRUKER AVANCE III 13C-NMR 11a IN DMSO-d6

O

O

O

O

NH O

O

38394041f1 (ppm)

38.8

239

.10

39.2

439

.38

39.5

239

.66

39.8

039

.93

11b

Page 72: kinase B (PknB) inhibitors: synthesis and SAR study

11c

Page 73: kinase B (PknB) inhibitors: synthesis and SAR study

11d

Page 74: kinase B (PknB) inhibitors: synthesis and SAR study

11e

Page 75: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

28.1

538

.80

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

4

55.9

8

63.8

9

77.7

8

112.

67

120.

81

126.

8812

9.37

130.

0013

4.69

140.

72

155.

6715

8.62

165.

05

190.

84

BRUKER AVANCE III 13C-NMR 11e IN DMSO-d6

O

O

O

NH O

O

O

11f

Page 76: kinase B (PknB) inhibitors: synthesis and SAR study

11g

Page 77: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

28.1

638

.81

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

4

55.6

056

.46

63.8

9

77.8

1

113.

7311

4.33

120.

69

127.

1612

9.44

140.

66

152.

9915

3.15

155.

69

165.

06

190.

44

BRUKER AVANCE III 13C-NMR 11g IN DMSO-d6

O

O

O

NH O

O

O

O

11h

Page 78: kinase B (PknB) inhibitors: synthesis and SAR study

11i

11j

Page 79: kinase B (PknB) inhibitors: synthesis and SAR study

11k

Page 80: kinase B (PknB) inhibitors: synthesis and SAR study

11l

Page 81: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

28.1

838

.81

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

4

64.1

0

77.8

4

117.

2912

0.24

125.

0613

0.41

131.

2713

1.59

136.

71

154.

6415

5.70

162.

1616

4.85

187.

50

BRUKER AVANCE III 13C-NMR 11l IN DMSO-d6

O

O

O

NH O

O

O

129130131132133f1 (ppm)

130.

41

130.

75

131.

27

131.

59

39.040.0f1 (ppm)

38.8

139

.10

39.2

439

.38

39.5

239

.66

39.8

039

.94

11m

Page 82: kinase B (PknB) inhibitors: synthesis and SAR study

-20-100102030405060708090100110120130140150160170180190200210f1 (ppm)

28.1

638

.77

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

3

64.1

7

77.8

2

124.

8412

5.05

126.

7712

8.21

128.

7312

9.71

129.

8113

2.10

133.

4513

3.74

140.

06

155.

69

164.

83

193.

07

BRUKER AVANCE III 13C-NMR 11m IN DMSO-d6

O

O

O

NH O

O

38394041f1 (ppm)

38.7

7

39.1

039

.24

39.3

839

.52

39.6

639

.80

39.9

3

125127129131133f1 (ppm)

124.

8412

5.05

126.

77

128.

21

128.

73

129.

7112

9.81

132.

10

133.

4513

3.74

11n

Page 83: kinase B (PknB) inhibitors: synthesis and SAR study

11o

11p

Page 84: kinase B (PknB) inhibitors: synthesis and SAR study

11q

Page 85: kinase B (PknB) inhibitors: synthesis and SAR study

11r

Page 86: kinase B (PknB) inhibitors: synthesis and SAR study

11s

Page 87: kinase B (PknB) inhibitors: synthesis and SAR study

11t

Page 88: kinase B (PknB) inhibitors: synthesis and SAR study